Clinical outbreak of linezolid-resistant Staphylococcus aureus in an intensive care unit.
about
Future challenges and treatment of Staphylococcus aureus bacteremia with emphasis on MRSAGloves, gowns and masks for reducing the transmission of meticillin-resistant Staphylococcus aureus (MRSA) in the hospital settingFocus on JNJ-Q2, a novel fluoroquinolone, for the management of community-acquired bacterial pneumonia and acute bacterial skin and skin structure infectionsNew Insight on Epidemiology and Management of Bacterial Bloodstream Infection in Patients with Hematological MalignanciesThe global spread of healthcare-associated multidrug-resistant bacteria: a perspective from AsiaResistance to linezolid caused by modifications at its binding site on the ribosomeMethicillin-resistant Staphylococcus aureus therapy: past, present, and futurePleuromutilins: use in food-producing animals in the European Union, development of resistance and impact on human and animal health[Current data and trends on methicillin-resistant Staphylococcus aureus (MRSA)].Treatment of hospital-acquired pneumonia with linezolid or vancomycin: a systematic review and meta-analysis.Tedizolid Phosphate: a Next-Generation Oxazolidinone.Emergence of linezolid resistance in a clinical Staphylococcus capitis isolate from Jiangsu Province of China in 2012.Telavancin for hospital-acquired pneumonia: clinical response and 28-day survivalInfective endocarditis; report from a main referral teaching hospital in Iran.Marinopyrrole derivatives as potential antibiotic agents against methicillin-resistant Staphylococcus aureus (III).Bacteria from Animals as a Pool of Antimicrobial Resistance Genes.A novel STK1-targeted small-molecule as an "antibiotic resistance breaker" against multidrug-resistant Staphylococcus aureus.Whole genome analysis of linezolid resistance in Streptococcus pneumoniae reveals resistance and compensatory mutations.Clinical practice guidelines by the infectious diseases society of america for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children.Safety and immunogenicity of a novel Staphylococcus aureus vaccine: results from the first study of the vaccine dose range in humansCfr-mediated linezolid-resistance among methicillin-resistant coagulase-negative staphylococci from infections of humans.Telavancin in the treatment of Staphylococcus aureus hospital-acquired and ventilator-associated pneumonia: clinical evidence and experience.Emergence of linezolid-resistant Staphylococcus aureus after prolonged treatment of cystic fibrosis patients in Cleveland, OhioLinezolid vs glycopeptide antibiotics for the treatment of suspected methicillin-resistant Staphylococcus aureus nosocomial pneumonia: a meta-analysis of randomized controlled trials.Current strategies for the prevention and management of central line-associated bloodstream infections.Low fitness cost of the multidrug resistance gene cfr.Randomized, double-blind, phase II, multicenter study evaluating the safety/tolerability and efficacy of JNJ-Q2, a novel fluoroquinolone, compared with linezolid for treatment of acute bacterial skin and skin structure infectionDissemination of the same cfr-carrying plasmid among methicillin-resistant Staphylococcus aureus and coagulase-negative staphylococcal isolates in ChinaPopulation biology of Gram-positive pathogens: high-risk clones for dissemination of antibiotic resistanceComparison of the pharmacokinetic properties of vancomycin, linezolid, tigecyclin, and daptomycin.Importance of Multifaceted Approaches in Infection Control: A Practical Experience from an Outbreak Investigation.Modeling the spread of methicillin-resistant Staphylococcus aureus (MRSA) outbreaks throughout the hospitals in Orange County, California.The order Bacillales hosts functional homologs of the worrisome cfr antibiotic resistance geneMolecular epidemiology of Staphylococcus epidermidis clinical isolates from U.S. hospitalsAntimicrobial stewardship of Chinese ministry of health reduces multidrug-resistant organism isolates in critically ill patients: a pre-post study from a single centerA microfluidic platform for rapid, stress-induced antibiotic susceptibility testing of Staphylococcus aureus.Methicillin resistant and susceptible Staphylococcus aureus: Appraising therapeutic approaches in the Northwest of IranIs it time to replace vancomycin in the treatment of methicillin-resistant Staphylococcus aureus infections?Oritavancin Activity Tested against Molecularly Characterized Staphylococci and Enterococci Displaying Elevated Linezolid MIC Results.Dissemination of a pSCFS3-like cfr-carrying plasmid in Staphylococcus aureus and Staphylococcus epidermidis clinical isolates recovered from hospitals in Ohio.
P2860
Q22305769-06A81905-D397-45A0-8411-564269F10582Q24186422-FF0DD70A-ABC6-411C-9FD1-3C3F909C8F11Q26746197-761588D4-D90E-445A-9D33-F6319B64C389Q26799580-5F51ED0D-70EA-4593-9224-CE8304E751DDQ27001437-24AACB41-625F-4A05-9787-8877C735DF28Q27006772-DC193F78-1276-4456-A6DA-AB5E4EB46C08Q27011165-B86E30B1-9120-4A67-B257-F8E7C86D3E0BQ27015971-02DA71A8-42BC-4B7D-89CB-9EF5EBF9D181Q30575519-19BC7DD7-AA7E-4196-A7D3-91967DB92D79Q33410942-28B575AA-352C-43DC-8E0F-7643AED93E1CQ33420646-06FFEE21-F8DC-4AD5-AE38-934B56637447Q33586058-2BEC3F4A-09F2-42BD-816F-52ADC6B936C9Q33622851-8F75855E-5942-42AD-974A-2938BF136252Q33652266-A9204F6E-3000-4DA0-8FDB-FA65CD986C75Q33736668-A695DE15-486A-46B0-A89C-2FB99D1B5316Q33836471-5D079D1B-3AC4-4701-A0E6-A84E67F69BD3Q33894853-FFC1B466-128C-4DCB-B739-2054C11616DBQ34049640-D25BA9C7-462D-48C9-BED8-078EBC15A3A6Q34157657-06D899AE-EECC-4EC0-AE9D-304C685DF8D5Q34431997-EAC45E4F-3916-4E4E-B63F-5E6720D868BBQ34600031-5D0371AA-EE4F-44FA-9BDF-DD06D692C7D8Q34677611-3A08AC24-1B29-49B5-BA12-54EACC007E4CQ34737606-B8A2460C-9BBA-486D-82D3-E1A094CDA0ABQ34923394-7DF28426-DE6D-4D36-94CC-E0A39AE66263Q35026591-B8DA4333-5F5B-409D-AD32-871124CCBA68Q35139469-8B46DDB4-A8EA-47A5-A07A-43CC7EA31533Q35598552-9FF3342E-0915-4C6D-9BB9-14A527FE4094Q35607766-421DE707-48B4-41E9-A92F-AD8380ED8D11Q35622545-F7130092-A25F-480D-87F3-235D4049591CQ35959546-663CCF1B-64A0-47E5-9D41-76D71A623DD6Q36056758-E42AC2E2-B3D6-411F-A2C6-1CED43B8A39AQ36071651-B2453B53-DE43-4CE6-A9E0-15AE6E669872Q36086450-2ECC332C-604A-4C84-9FAD-87DB8BD1DB68Q36172406-350A1B30-FDAF-407B-9517-77EE8C86712FQ36204188-64D5579E-63FB-405F-8D35-70D0EC4DA388Q36371874-7C8B3F64-CD29-4F5D-8CB6-2A3E67A91C80Q36624479-A3788446-99BF-4C01-9E74-39C6B5E1DEF5Q36856946-B4722799-5F60-489E-9C23-3D3F5A32C1FDQ36933484-4760F3BE-80A2-47DD-BB08-990A11BF9D95Q36969913-C3026F05-D8C6-4C13-B3A3-3A5E5D966E0D
P2860
Clinical outbreak of linezolid-resistant Staphylococcus aureus in an intensive care unit.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh-hant
name
Clinical outbreak of linezolid-resistant Staphylococcus aureus in an intensive care unit.
@en
Clinical outbreak of linezolid-resistant Staphylococcus aureus in an intensive care unit.
@nl
type
label
Clinical outbreak of linezolid-resistant Staphylococcus aureus in an intensive care unit.
@en
Clinical outbreak of linezolid-resistant Staphylococcus aureus in an intensive care unit.
@nl
prefLabel
Clinical outbreak of linezolid-resistant Staphylococcus aureus in an intensive care unit.
@en
Clinical outbreak of linezolid-resistant Staphylococcus aureus in an intensive care unit.
@nl
P2093
P356
P1476
Clinical outbreak of linezolid-resistant Staphylococcus aureus in an intensive care unit
@en
P2093
Ana Arribi
Beatriz Peláez
Fernando Martínez Sagasti
Gracia Morales
José Fereres
Juan Picazo
María Angeles De la Torre
María José Tolón
Miguel Sánchez García
Nicolás García
P304
P356
10.1001/JAMA.2010.757
P407
P577
2010-06-01T00:00:00Z